Verrica Pharmaceuticals Inc (NASDAQ:VRCA)
| 8.19 Delayed Data As of Jan 19 |  +0.09 / +1.12%Today’s Change | 7.83 Today|||52-Week Range 18.42 | -10.59% Year-to-Date |
Latest VRCA News | Press Releases
No recent news for Verrica Pharmaceuticals Inc.
Today’s Trading
| Previous close | 8.01 |
| Today’s open | 7.97 |
| Day’s range | 7.97 - 8.29 |
| Volume | 34,616 |
| Average volume (3 months) | 99,920 |
| Market cap | $252.1M |
Data as of 4:00pm ET, 01/19/2022
Growth & Valuation
| Earnings growth (last year) | -50.77% |
| Earnings growth (this year) | +14.91% |
| Earnings growth (next 5 years) | -20.18% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 7.06 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| HROWHarrow Health Inc | -0.03 | -0.36% |
| SMMTSummit Therapeutics ... | -0.01 | -0.44% |
| MISTMilestone Pharmaceut... | -0.02 | -0.26% |
| CTICCTI Biopharma Corp | +0.12 | +5.63% |
Data as of 4:00pm ET, 01/19/2022
Financials
| Next reporting date | March 10, 2022 |
| EPS forecast (this quarter) | -$0.50 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$42.7M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters West Chester, Pennsylvania |
Forecasts
